Literature DB >> 23192896

Pulmonary hypertension following haematopoietic stem cell transplantation for primary haemophagocytic lymphohistiocytosis.

Ulrike Zeilhofer1, Michael Ashworth, Persis Amrolia, Anupama Rao, Robert Chiesa, Paul Veys, Kanchan Rao.   

Abstract

We report two children who developed severe, fatal pulmonary hypertension (PHT) after mismatched unrelated donor cord blood transplantation using reduced intensity conditioning for HLH. PHT was diagnosed on post mortem lung biopsies with no evidence of HLH, pulmonary veno-occlusive disease, infection or of idiopathic pulmonary hypertension. PHT may be an association with HLH and physicians treating HLH should be aware of this potential association.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 23192896     DOI: 10.1002/pbc.24405

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  3 in total

1.  A case of pulmonary arterial hypertension associated with adult hemophagocytic lymphohistiocytosis.

Authors:  Julius Koifman; John Granton; John Thenganatt
Journal:  Pulm Circ       Date:  2016-12       Impact factor: 3.017

2.  Toxicities of busulfan/melphalan versus carboplatin/etoposide/melphalan for high-dose chemotherapy with stem cell rescue for high-risk neuroblastoma.

Authors:  A V Desai; M B Heneghan; Y Li; N J Bunin; S A Grupp; R Bagatell; A E Seif
Journal:  Bone Marrow Transplant       Date:  2016-05-09       Impact factor: 5.483

3.  Resource Utilization and Toxicities After Carboplatin/Etoposide/Melphalan and Busulfan/Melphalan for Autologous Stem Cell Rescue in High-Risk Neuroblastoma Using a National Administrative Database.

Authors:  Ami V Desai; Alix E Seif; Yimei Li; Kelly Getz; Brian T Fisher; Vera Huang; Adjoa Mante; Richard Aplenc; Rochelle Bagatell
Journal:  Pediatr Blood Cancer       Date:  2016-01-21       Impact factor: 3.167

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.